UVA to Expand Bone Marrow Transplant and Immunotherapy Offerings
As part of its ongoing mission to expand and optimize its clinical research infrastructure and provide patients access to the most advanced cancer treatment and prevention strategies available, UVA Cancer Center welcomes two world-class clinicians and researchers to grow its bone marrow transplant program.
With a Growing Team of Physician-Scientists, UVA Is Increasing Immunotherapy Trials for Cancer
An expert in immunotherapy, Lawrence G. Lum, MD, DSc joins UVA Cancer Center as the scientific director of bone marrow transplantation. One of Lum’s priorities is pioneering a new method of activating the body’s own T cells to target tumor cells.